Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with an appalling
prognosis. The failure of anti-inflammatory therapies coupled with the observation that …

Idiopathic pulmonary fibrosis (IPF) is a unique type of chronic fibrosing lung disease of
unknown etiology. The sequence of the pathogenic mechanisms is unknown, but the …

Idiopathic pulmonary fibrosis (IPF), also termed cryptogenic fibrosing alveolitis, is a
clinicopathological syndrome characterised by cough, exertional dyspneoa, basilar crackles …

Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive and devastating interstitial
lung disease of unknown etiology, where the normal lung architecture is lost and replaced …

Idiopathic pulmonary fibrosis (IPF) is characterized by the progressive and ultimately fatal
accumulation of fibroblasts and extracellular matrix in the lung that distorts its architecture …

Idiopathic pulmonary fibrosis (IPF), a progressive and relentless lung scarring of unknown
etiology, has been recognized as the most lethal interstitial lung disease. Despite the …

Idiopathic pulmonary fibrosis (IPF) is a chronic, relentlessly progressive fibrosing disease of
the lung of unknown etiology. Significant progress has been made in recent years in …

Idiopathic Pulmonary Fibrosis (IPF) is characterized by injury and loss of lung epithelial
cells, accumulation of fibroblasts/myofibroblasts and abnormal remodeling of the lung …

IPF (idiopathic pulmonary fibrosis) is a chronic progressive disease of unknown aetiology
without effective treatment. IPF is characterized by excessive collagen deposition within the …

Aim This study explored the cellular and biological interrelationships involved in Idiopathic
Pulmonary Fibrosis (IPF) lung tissue remodelling using immunohistochemical analysis …